The potential of topical DNA vaccines adjuvanted by cytokines

Julianna Lisziewicz, Sandra A. Calarota, Franco Lori

Research output: Contribution to journalArticle

Abstract

To improve the efficacy of DNA immunization epidermal Langerhans cells are attractive targets to deliver antigen-encoding plasmid DNA. Topical vaccination with naked plasmid DNA has been shown to induce immune responses, and their potency might be improved by chemical and physical methods aimed to enhance the efficiency of plasmid DNA delivery into the skin. Cytokines have also been evaluated as adjuvants for DNA vaccines because they influence the host immune response. This review focuses on the action of several cytokines tested as molecular adjuvants for DNA vaccines and the combination of them with the DermaVir Patch vaccine. DermaVir vaccine, topically administered under a patch, consists of a plasmid DNA that is chemically formulated into a nanoparticle to support vaccine delivery into epidermal Langerhans cells and to induce antigen-specific memory T cells.

Original languageEnglish
Pages (from-to)1563-1574
Number of pages12
JournalExpert Opinion on Biological Therapy
Volume7
Issue number10
DOIs
Publication statusPublished - Oct 2007

Fingerprint

DNA Vaccines
Cytokines
Plasmids
DNA
Vaccines
Langerhans Cells
Immunization
Antigens
T-cells
Nanoparticles
Skin
Vaccination
T-Lymphocytes
Data storage equipment

Keywords

  • Cellular immunity
  • Cytokine adjuvant
  • Dendritic cells
  • DermaVir
  • HIV-1
  • Langerhans cells
  • Topical DNA vaccines

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology
  • Pharmacology

Cite this

The potential of topical DNA vaccines adjuvanted by cytokines. / Lisziewicz, Julianna; Calarota, Sandra A.; Lori, Franco.

In: Expert Opinion on Biological Therapy, Vol. 7, No. 10, 10.2007, p. 1563-1574.

Research output: Contribution to journalArticle

Lisziewicz, Julianna ; Calarota, Sandra A. ; Lori, Franco. / The potential of topical DNA vaccines adjuvanted by cytokines. In: Expert Opinion on Biological Therapy. 2007 ; Vol. 7, No. 10. pp. 1563-1574.
@article{0c193806c9df41e3a213746a94be0e96,
title = "The potential of topical DNA vaccines adjuvanted by cytokines",
abstract = "To improve the efficacy of DNA immunization epidermal Langerhans cells are attractive targets to deliver antigen-encoding plasmid DNA. Topical vaccination with naked plasmid DNA has been shown to induce immune responses, and their potency might be improved by chemical and physical methods aimed to enhance the efficiency of plasmid DNA delivery into the skin. Cytokines have also been evaluated as adjuvants for DNA vaccines because they influence the host immune response. This review focuses on the action of several cytokines tested as molecular adjuvants for DNA vaccines and the combination of them with the DermaVir Patch vaccine. DermaVir vaccine, topically administered under a patch, consists of a plasmid DNA that is chemically formulated into a nanoparticle to support vaccine delivery into epidermal Langerhans cells and to induce antigen-specific memory T cells.",
keywords = "Cellular immunity, Cytokine adjuvant, Dendritic cells, DermaVir, HIV-1, Langerhans cells, Topical DNA vaccines",
author = "Julianna Lisziewicz and Calarota, {Sandra A.} and Franco Lori",
year = "2007",
month = "10",
doi = "10.1517/14712598.7.10.1563",
language = "English",
volume = "7",
pages = "1563--1574",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Taylor and Francis Ltd.",
number = "10",

}

TY - JOUR

T1 - The potential of topical DNA vaccines adjuvanted by cytokines

AU - Lisziewicz, Julianna

AU - Calarota, Sandra A.

AU - Lori, Franco

PY - 2007/10

Y1 - 2007/10

N2 - To improve the efficacy of DNA immunization epidermal Langerhans cells are attractive targets to deliver antigen-encoding plasmid DNA. Topical vaccination with naked plasmid DNA has been shown to induce immune responses, and their potency might be improved by chemical and physical methods aimed to enhance the efficiency of plasmid DNA delivery into the skin. Cytokines have also been evaluated as adjuvants for DNA vaccines because they influence the host immune response. This review focuses on the action of several cytokines tested as molecular adjuvants for DNA vaccines and the combination of them with the DermaVir Patch vaccine. DermaVir vaccine, topically administered under a patch, consists of a plasmid DNA that is chemically formulated into a nanoparticle to support vaccine delivery into epidermal Langerhans cells and to induce antigen-specific memory T cells.

AB - To improve the efficacy of DNA immunization epidermal Langerhans cells are attractive targets to deliver antigen-encoding plasmid DNA. Topical vaccination with naked plasmid DNA has been shown to induce immune responses, and their potency might be improved by chemical and physical methods aimed to enhance the efficiency of plasmid DNA delivery into the skin. Cytokines have also been evaluated as adjuvants for DNA vaccines because they influence the host immune response. This review focuses on the action of several cytokines tested as molecular adjuvants for DNA vaccines and the combination of them with the DermaVir Patch vaccine. DermaVir vaccine, topically administered under a patch, consists of a plasmid DNA that is chemically formulated into a nanoparticle to support vaccine delivery into epidermal Langerhans cells and to induce antigen-specific memory T cells.

KW - Cellular immunity

KW - Cytokine adjuvant

KW - Dendritic cells

KW - DermaVir

KW - HIV-1

KW - Langerhans cells

KW - Topical DNA vaccines

UR - http://www.scopus.com/inward/record.url?scp=35348911861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348911861&partnerID=8YFLogxK

U2 - 10.1517/14712598.7.10.1563

DO - 10.1517/14712598.7.10.1563

M3 - Article

C2 - 17916048

AN - SCOPUS:35348911861

VL - 7

SP - 1563

EP - 1574

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 10

ER -